Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Masked hypertension and elevated nighttime BP are associated with increased risk of hypertensive target organ damage and adverse cardiovascular and renal outcomes in patients with normal kidney function. The significance of masked hypertension for these risks in patients with CKD is less well defined. The objective of this study was to evaluate the association between masked hypertension and kidney function and markers of cardiovascular target organ damage, and to determine whether this relationship was consistent among those with and without elevated nighttime BP. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional study. We performed 24-hour ambulatory BP in 1492 men and women with CKD enrolled in the Chronic Renal Insufficiency Cohort Study. We categorized participants into controlled BP, white-coat, masked, and sustained hypertension on the basis of clinic and 24-hour ambulatory BP. We obtained echocardiograms and measured pulse wave velocity in 1278 and 1394 participants, respectively. RESULTS: The percentages of participants with controlled BP, white-coat, masked, and sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with controlled BP, masked hypertension independently associated with low eGFR (-3.2 ml/min per 1.73 m(2); 95% confidence interval, -5.5 to -0.9), higher proteinuria (+0.9 unit higher in log2 urine protein; 95% confidence interval, 0.7 to 1.1), and higher left ventricular mass index (+2.52 g/m(2.7); 95% confidence interval, 0.9 to 4.1), and pulse wave velocity (+0.92 m/s; 95% confidence interval, 0.5 to 1.3). Participants with masked hypertension had lower eGFR only in the presence of elevated nighttime BP (-3.6 ml/min per 1.73 m(2); 95% confidence interval, -6.1 to -1.1; versus -1.4 ml/min per 1.73 m(2); 95% confidence interval, -6.9 to 4.0, among those with nighttime BP <120/70 mmHg; P value for interaction with nighttime systolic BP 0.002). CONCLUSIONS: Masked hypertension is common in patients with CKD and associated with lower eGFR, proteinuria, and cardiovascular target organ damage. In patients with CKD, ambulatory BP characterizes the relationship between BP and target organ damage better than BP measured in the clinic alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A lower eGFR is associated with resistant hypertension, masked hypertension, and elevated nighttime BP values. 92”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertension is a major risk factor for the development and progression of albuminuria and any form of CKD. 92”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [92]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Self-citationLang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Vlachopoulos, C., Aznaouridis, K., O'Rourke, M. F., Safar, M. E., Baou, K., & Stefanadis, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq024 · Cited by 1,363
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Self-citationLash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619
Self-citationAortic pulse wave velocity index and mortality in end-stage renal disease
Blacher, J., Safar, M. E., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00932.x · Cited by 532
Fagard, R. H., & Cornelissen, V. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ef6185 · Cited by 480
Management of hypertension: summary of NICE guidance
Krause, T., Lovibond, K., Caulfield, M., McCormack, T., Williams, B., & on behalf of the Guideline Development Group (2011) · BMJ · doi:10.1136/bmj.d4891 · Cited by 477
O'Brien, E. (2000) · BMJ · doi:10.1136/bmj.320.7242.1128 · Cited by 452
Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.014 · Cited by 423 · cited 1×
“Among all CRIC participants, clinic BP was controlled at the initial visit in approximately 72% of participants, with a higher rate observed in those who went on to undergo ABPM (32).”
BackgroundSelf-citationPiper, M. A., Evans, C. V., Burda, B. U., Margolis, K. L., O'Connor, E., & Whitlock, E. P. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1539 · Cited by 380
Liu, J. E., Roman, M. J., Pini, R., Schwartz, J. E., Pickering, T. G., & Devereux, R. B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00003 · Cited by 354
Pierdomenico, S. D., & Cuccurullo, F. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.203 · Cited by 349
Minutolo, R., Agarwal, R., Borrelli, S., Chiodini, P., Bellizzi, V., Nappi, F., Cianciaruso, B., Zamboli, P., Conte, G., Gabbai, F. B., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.230 · Cited by 287
Pogue, V., Rahman, M., Lipkowitz, M., Toto, R., Miller, E., Faulkner, M., Rostand, S., Hiremath, L., Sika, M., Kendrick, C., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.115154 · Cited by 282
Self-citationAgarwal, R., & Andersen, M. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000247 · Cited by 252
Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study
Anderson, A. H., Yang, W., Hsu, C.-Y., Joffe, M. M., Leonard, M. B., Xie, D., Chen, J., Greene, T., Jaar, B. G., Kao, P., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.012 · Cited by 237
Self-citationHigh prevalence of masked uncontrolled hypertension in people with treated hypertension
Banegas, J. R., Ruilope, L. M., de la Sierra, A., de la Cruz, J. J., Gorostidi, M., Segura, J., Martell, N., Garcia-Puig, J., Deanfield, J., & Williams, B. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu016 · Cited by 223
Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary Study
Townsend, R. R., Wimmer, N. J., Chirinos, J. A., Parsa, A., Weir, M., Perumal, K., Lash, J. P., Chen, J., Steigerwalt, S. P., Flack, J., et al. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.240 · Cited by 218
Self-citationStehouwer, C. D. A., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., & Bouter, L. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09211.x · Cited by 211
Cuspidi, C., Meani, S., Salerno, M., Valerio, C., Fusi, V., Severgnini, B., Lonati, L., Magrini, F., & Zanchetti, A. (2004) · Journal of Hypertension · doi:10.1097/00004872-200402000-00010 · Cited by 196
Franklin, S. S., Thijs, L., Hansen, T. W., Li, Y., Boggia, J., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180653 · Cited by 184
Fukuda, M., Munemura, M., Usami, T., Nakao, N., Takeuchi, O., Kamiya, Y., Yoshida, A., & Kimura, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00419.x · Cited by 181
Farmer, C. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.11.2301 · Cited by 164
Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes
Wijkman, M. O., Länne, T., Engvall, J. E., Lindström, T., Östgren, C. J., & Nyström, F. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1369-9 · Cited by 148
Masked Hypertension and White-Coat Hypertension in Chronic Kidney Disease: A Meta-analysis
Bangash, F., & Agarwal, R. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05391008 · Cited by 134 · cited 1×
“and a crosssectional study from Spain, masked hypertension was present in less than 10% of CKD patients (30,31).”
BackgroundA Longitudinal Study of Left Ventricular Function and Structure from CKD to ESRD: The CRIC Study
Bansal, N., Keane, M. G., Delafontaine, P., Dries, D. L., Foster, E., Gadegbeku, C. A., Go, A. S., Hamm, L. L., Kusek, J. W., OJO, A. O., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06020612 · Cited by 130
Self-citationMinutolo, R., Gabbai, F. B., Agarwal, R., Chiodini, P., Borrelli, S., Bellizzi, V., Nappi, F., Stanzione, G., Conte, G., & Nicola, L. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.06.014 · Cited by 124
Suliman, M. E., Yılmaz, M. İ., Carrero, J. J., Qureshi, A. R., Sağlam, M., İpçioğlu, O. M., Yenicesu, M., Tong, M., Heimbürger, O., Barany, P. F., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03960907 · Cited by 120
Blood Pressure Measurement: Clinic, Home, Ambulatory, and Beyond
Drawz, P. E., Abdalla, M., & Rahman, M. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.01.026 · Cited by 103
Self-citationGorostidi, M., Sarafidis, P. A., de la Sierra, A., Segura, J., de la Cruz, J. J., Banegas, J. R., & Ruilope, L. M. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.025 · Cited by 102
Target organ damage and masked hypertension in the general population: the Finn-Home study
Hänninen, M.-R. A., Niiranen, T., Puukka, P. J., Kesäniemi, Y. A., Kähönen, M. A. P., & Jula, A. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835fa5dc · Cited by 101
Masked Uncontrolled Hypertension in CKD
Agarwal, R., Pappas, M. K., & Sinha, A. D. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030243 · Cited by 92
Relationship between Ambulatory BP and Clinical Outcomes in Patients with Hypertensive CKD
Gabbai, F. B., Rahman, M., Hu, B., Appel, L. J., Charleston, J., Contreras, G., Faulkner, M. L., Hiremath, L., Jamerson, K. A., Lea, J. P., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11301111 · Cited by 91
Self-citationMATSUI, Y., EGUCHI, K., ISHIKAWA, J., HOSHIDE, S., SHIMADA, K., & KARIO, K. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.10.008 · Cited by 82
Association of Cardiac Troponin T With Left Ventricular Structure and Function in CKD
Mishra, R., Li, Y., deFilippi, C. R., Fischer, M. J., Yang, W. P., Keane, M. G., Chen, J., He, J., Kallem, R. R., Horwitz, E. J., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.034 · Cited by 82
Self-citationClinical Correlates of Ambulatory BP Monitoring among Patients with CKD
Iimuro, S., Imai, E., Watanabe, T., Nitta, K., Akizawa, T., Matsuo, S., Makino, H., Ohashi, Y., & Hishida, A. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06470612 · Cited by 69
Cuspidi, C., Michev, I., Meani, S., Severgnini, B., Fusi, V., Corti, C., Salerno, M., Valerio, C., Magrini, F., & Zanchetti, A. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001546 · Cited by 62
Muxfeldt, E. S., Fiszman, R., de Souza, F., Viegas, B., Oliveira, F. C., & Salles, G. F. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185405 · Cited by 59
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease
Minutolo, R., Borrelli, S., Scigliano, R., Bellizzi, V., Chiodini, P., Cianciaruso, B., Nappi, F., Zamboli, P., Conte, G., & Nicola, L. D. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm164 · Cited by 55
Endothelial-Dependent Flow-Mediated Dilation in African Americans With Masked-Hypertension
Veerabhadrappa, P., Diaz, K. M., Feairheller, D. L., Sturgeon, K. M., Williamson, S. T., Crabbe, D. L., Kashem, A. M., & Brown, M. D. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.103 · Cited by 39
Paoletti, E., Bellino, D., Amidone, M., Rolla, D., & Cannella, G. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.6.778 · Cited by 25
Wang, C., Gong, W.-Y., Zhang, J., Peng, H., Tang, H., Liu, X., Ye, Z. C., & Lou, T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.051 · Cited by 12
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Metadata
- Authors
- Drawz, P. E., Alper, A. B., Anderson, A. H., Brecklin, C. S., Charleston, J., Chen, J., Deo, R., Fischer, M. J., He, J., Hsu, C.-Y., Huan, Y., Keane, M. G., Kusek, J. W., Makos, G. K., Miller, E. R., Soliman, E. Z., Steigerwalt, S. P., Taliercio, J. J., Townsend, R. R., Weir, M. R., Wright, J. T., Xie, D., & Rahman, M.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Drawz, Paul E.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-04
- Volume
- 11
- Issue
- 4
- Pages
- 642-652
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC4822674
- OpenAlex
- W2278752373
- Cited by
- 199
- References
- 47
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 13 · 2022: 23 · 2021: 20 · 2020: 31 · 2019: 28 · 2018: 23 · 2017: 13 · 2016: 8
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Nephrology
- National Institutes of Health (UL1TR000114, UL1TR000433, 5k23dk087919-05, UL1TR000424, UL1TR000003, UL1TR000439)
- National Institute of General Medical Sciences (P30GM103337)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK087919, K01DK092353, U01DK060990, DK 067390, R01DK067390, R01DK139225, U01DK060984, U01DK060902, U01DK060980, U01DK061022, U01DK060963, U01DK061021, U01DK061028)
- National Center for Research Resources (UL1RR024131, M01RR016500, UL1RR029879)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- masked hypertension, nocturnal blood pressure, chronic kidney disease, white coat hypertension, sustained hypertension, estimated glomerular filtration rate, proteinuria, left ventricular mass, pulse wave velocity, ambulatory blood pressure monitoring, hypertension control, Chronic Renal Insufficiency Cohort Study, cardiovascular risk stratification, cardiovascular risk reclassification
- MeSH terms
- Aged, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Kidney Diseases, Male, Middle Aged, Cohort Studies, Prevalence, Renal Insufficiency, Chronic, Masked Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.